We are live on ! Find out more
Norges Bank

Norges Bank Portfolio holdings

AUM $935B
 

Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.

This Fund
S&P 500
This Quarter Est. Return
+26.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$347B
AUM Growth
+$66.7B
Cap. Flow
+$5.55B
Cap. Flow %
1.6%
Top 10 Hldgs %
22.34%
Holding
2,120
New
74
Increased
993
Reduced
738
Closed
44

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$864M
2
TMUS icon
T-Mobile US
TMUS
+$580M
3
META icon
Meta Platforms (Facebook)
META
+$367M
4
ABBV icon
AbbVie
ABBV
+$348M
5
BLK icon
Blackrock
BLK
+$335M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$692M
2
RTN
Raytheon Company
RTN
+$368M
3
BMY icon
Bristol-Myers Squibb
BMY
+$279M
4
V icon
Visa
V
+$237M
5
INTC icon
Intel
INTC
+$187M

Sector Composition

Rank Sector Weight
1 Technology 22.84%
2 Healthcare 13.58%
3 Financials 13.55%
4 Consumer Discretionary 13.35%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADCT icon
2051
ADC Therapeutics
ADCT
$134M
$468K ﹤0.01%
+10,000
New +$380K
QNCX icon
2052
Quince Therapeutics
QNCX
$22.9M
$463K ﹤0.01%
+50
New +$458K
SKY icon
2053
Champion Homes
SKY
$4.37B
$443K ﹤0.01%
18,205
– –
HCAT icon
2054
Health Catalyst
HCAT
$154M
$438K ﹤0.01%
15,000
– –
XP icon
2055
XP
XP
$8.81B
$424K ﹤0.01%
10,081
-25,175
-71% -$772K
ORIC icon
2056
Oric Pharmaceuticals
ORIC
$1.15B
$422K ﹤0.01%
+12,500
New +$399K
RIO icon
2057
Rio Tinto
RIO
$158B
$413K ﹤0.01%
7,353
– –
TGTX icon
2058
TG Therapeutics
TGTX
$7.96B
$390K ﹤0.01%
+20,000
New +$322K
YORW icon
2059
York Water
YORW
$502M
$356K ﹤0.01%
7,426
– –
AKUS
2060
DELISTED
Akouos Inc
AKUS
$338K ﹤0.01%
+15,000
New +$334K
NTLA icon
2061
Intellia Therapeutics
NTLA
$1.49B
$315K ﹤0.01%
+15,000
New +$255K
MGNI icon
2062
Magnite
MGNI
$2.76B
$312K ﹤0.01%
46,834
– –
DNR
2063
DELISTED
Denbury Resources, Inc.
DNR
$308K ﹤0.01%
1,114,308
-5,254,901
-83% -$1.58M
SDC
2064
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$297K ﹤0.01%
37,647
-1,611,886
-98% -$10.9M
XYF
2065
X Financial
XYF
$190M
$284K ﹤0.01%
105,000
– –
LDL
2066
DELISTED
Lydall, Inc.
LDL
$264K ﹤0.01%
19,436
– –
PAHC icon
2067
Phibro Animal Health
PAHC
$1.47B
$257K ﹤0.01%
+9,773
New +$243K
RES icon
2068
RPC Inc
RES
$1.24B
$238K ﹤0.01%
77,242
– –
BEAM icon
2069
Beam Therapeutics
BEAM
$2.63B
$233K ﹤0.01%
8,324
-11,676
-58% -$252K
DBVT
2070
DBV Technologies
DBVT
$799M
$220K ﹤0.01%
5,000
– –
WBD icon
2071
Warner Bros
WBD
$65.9B
$215K ﹤0.01%
10,196
-139,264
-93% -$3.01M
RDS.A
2072
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$180K ﹤0.01%
5,513
– –
SCOR icon
2073
Comscore
SCOR
$106M
$126K ﹤0.01%
2,036
-4,686
-70% -$281K
BCOM
2074
DELISTED
B Communications Ltd
BCOM
$124K ﹤0.01%
64,029
– –
TUP
2075
DELISTED
Tupperware Brands Corporation
TUP
$103K ﹤0.01%
21,787
– –
81 82
83
84 85

Similar funds

CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
CWM
CIBC World Markets New York $20.8B AUM
VRS
Virginia Retirement Systems Richmond, Virginia $16.8B AUM 25.91% 1-Year Est. Return
FAF
Första AP-fonden Stockholm, Sweden $16.8B AUM 29.64% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
CIM
CCLA Investment Management London, United Kingdom $6.23B AUM 5.02% 1-Year Est. Return

Norges Bank's Q2 2020 Portfolio in Review

As of Q2 2020, Norges Bank held 2,120 positions worth $347B, up 24% from $281B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Norges Bank's Q2 2020 filing shows 74 new, 993 increased, 738 reduced and 44 closed positions. Its largest new stake was Nikola Corporation Common Stock: 333,333 shares worth $675M. The largest sale was Allergan plc, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Norges Bank's largest Q2 2020 buy was Nikola Corporation Common Stock: 333,333 shares worth $675M.
  • Norges Bank added most to Walmart Inc in Q2 2020, an estimated $864M increase.
  • Norges Bank's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $279M.
  • Norges Bank fully exited Allergan plc in Q2 2020, selling an estimated $692M.
  • Norges Bank's ten largest holdings make up 22% of its $347B portfolio in Q2 2020.
  • Norges Bank opened 74 new positions and closed 44 in Q2 2020.
  • Norges Bank's portfolio value rose 24% quarter-over-quarter to $347B.

Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.